{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:41:50Z","timestamp":1774644110739,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12185-022-03331-x","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T13:04:05Z","timestamp":1650114245000},"page":"442-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-5017","authenticated-orcid":false,"given":"Patryk","family":"Sobieralski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bieniaszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Leszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"\u017buk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Was\u0105g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-8936","authenticated-orcid":false,"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"3331_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41379-018-0014-x","volume":"31","author":"H Kurt","year":"2018","unstructured":"Kurt H, Zheng L, Kantarjian HM, Tang G, Ravandi-Kashani F, Garcia-Manero G, et al. Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome. Mod Pathol. 2018;31:1141\u201354.","journal-title":"Mod Pathol"},{"key":"3331_CR2","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.5858\/2007-131-1719-TOPVTC","volume":"131","author":"I Mirza","year":"2007","unstructured":"Mirza I, Frantz C, Clarke G, Voth AJ, Turner R. Transformation of polycythemia vera to chronic myelogenous leukemia. Arch Pathol Lab Med. 2007;131:1719\u201324.","journal-title":"Arch Pathol Lab Med"},{"key":"3331_CR3","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3816\/CLM.2009.n.080","volume":"9","author":"SRK Pingali","year":"2009","unstructured":"Pingali SRK, Mathiason M, Lovrich S, Go R. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation. Clin Lymphoma Myeloma. 2009;9:E25\u20139.","journal-title":"Clin Lymphoma Myeloma"},{"key":"3331_CR4","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1111\/ijlh.12398","volume":"37","author":"Z Chen","year":"2015","unstructured":"Chen Z, Wang W, Verstovsek S, Cortes JE, Medeiros LJ, Hu S. Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm. Int J Lab Hematol. 2015;37:e150\u20132.","journal-title":"Int J Lab Hematol"},{"key":"3331_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/modpathol.2017.182","volume":"31","author":"CR Soderquist","year":"2018","unstructured":"Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, et al. Myeloproliferative neoplasms with concurrent BCR\u2013ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018;31:690\u2013704.","journal-title":"Mod Pathol"},{"key":"3331_CR6","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00277-016-2827-3","volume":"95","author":"JMS Diamond","year":"2016","unstructured":"Diamond JMS, de Almeida AM, Belo HJLMR, da Costa MPGPG, Cabe\u00e7adas JMVS, de Abecasis MMSF. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR\u2013ABL1 fusion gene. Ann Hematol. 2016;95:2101\u20134.","journal-title":"Ann Hematol"},{"key":"3331_CR7","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1182\/blood-2014-12-616847","volume":"125","author":"I Bonzheim","year":"2015","unstructured":"Bonzheim I, Mankel B, Klapthor P, Schmidt J, Hinrichsen T, Wachter O, et al. CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation. Blood. 2015;125:2309\u201311.","journal-title":"Blood"},{"key":"3331_CR8","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","volume":"109","author":"K Hussein","year":"2007","unstructured":"Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Buesche G, et al. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2 V617F mutation [4]. Blood. 2007;109:4106\u20137.","journal-title":"Blood"},{"key":"3331_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJMc1413718","volume":"372","author":"X Cabagnols","year":"2015","unstructured":"Cabagnols X, Cayuela J-M, Vainchenker W. A CALR mutation preceding BCR\u2013ABL1 in an atypical myeloproliferative neoplasm. N Engl J Med. 2015;372:688\u201390.","journal-title":"N Engl J Med"},{"key":"3331_CR10","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1080\/10428194.2019.1639162","volume":"60","author":"F Autore","year":"2019","unstructured":"Autore F, Sor\u00e0 F, Chiusolo P, Annunziata M, Iurlo A, Cattaneo D, et al. \u2018Secondary chronic myeloid leukemia\u2019: comparison between patients previously exposed or not to chemo- and\/or radiotherapy. Leuk Lymphoma. 2019;60:3584\u20136.","journal-title":"Leuk Lymphoma"},{"key":"3331_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ajcp\/aqy050","volume":"150","author":"LH Yang","year":"2018","unstructured":"Yang LH, Su P, Luedke C, Lu CM, Louissaint A, McCall CM, et al. Chronic myeloid leukemia following treatment for primary neoplasms or other medical conditions: a report of 21 cases and review of the literature. Am J Clin Pathol. 2018;150:246\u201358.","journal-title":"Am J Clin Pathol"},{"key":"3331_CR12","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.3324\/haematol.2018.202952","volume":"104","author":"A Stengel","year":"2019","unstructured":"Stengel A, Jeromin S, Haferlach T, Meggendorfer M, Kern W, Haferlach C. Detection and characterization of homozygosity of mutated CALR by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high CALR mutation loads or with progressive disease. Haematologica. 2019;104:e187\u201390.","journal-title":"Haematologica"},{"key":"3331_CR13","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369:2379\u201390.","journal-title":"N Engl J Med"},{"key":"3331_CR14","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41375-020-01037-9","volume":"34","author":"H Zhao","year":"2020","unstructured":"Zhao H, Deininger MW. Declaration of BCR\u2013ABL1 independence. Leukemia. 2020;34:2827\u201336.","journal-title":"Leukemia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T16:09:11Z","timestamp":1661011751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03331-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3331"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03331-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}